HER2-low Hormone Receptor Positive Breast Cancer trials recruiting in Michigan

Fewer than 3 recruiting trials found.

All HER2-low Hormone Receptor Positive Breast Cancer trials nationally

Cities in Michigan

Recruiting trials in Michigan

• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
  NCT07287917 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit